ACP, Annals of Internal Medicine host third virtual COVID-19 vaccine forum for physicians
ACP's and Annals of Internal Medicine's third virtual COVID-19 vaccine forum on Jan. 22 focused on the allocation and distribution of available vaccines.
Four invited experts offered their perspectives, including Capt. Amanda Cohn, MD, chief medical officer of the National Center for Immunizations and Respiratory Diseases (NCIRD) and executive secretary of the Advisory Committee on Immunization Practices; David Fairchild, MD, MPH, chief medical officer of CVS MinuteClinic and professor of medicine at University of Massachusetts Medical School; Mark Levine, MD, MACP, Vermont's commissioner of health; and Wayne J. Riley, MD, MPH, MBA, MACP, president of SUNY Downstate Health Sciences University and an ACP President Emeritus. Jason M. Goldman, FACP, a member of ACP's Board of Regents and a practicing internist in Florida, moderated the discussion and posed questions from attendees to the participants.
The full recording is available for replay and is published in Annals of Internal Medicine along with an accompanying commentary.
PPE marketplace now open to ACP Members
ACP's partnership with Project N95 now extends to an online marketplace with ongoing availability of vetted personal protective equipment (PPE). Members no longer have to wait for ACP to run short-term bulk order events to fulfill their PPE needs. Products and pricing will vary from time to time, but Project N95 seeks to have N95 masks, gloves, and other highly needed items available on an ongoing basis. Project N95 can only ship to U.S. addresses. Project N95 will offer special sales and prioritized customer service to ACP members.
More information, including how to order from Project N95, is on ACP's website.
New resources available on how to improve treatment of patients with obesity
ACP's new comprehensive learning series, providing practical guidance to support members and their medical teams in treating patients with obesity, is available in ACP's Online Learning Center.
The series offers CME/MOC credit that is free for ACP members. Three web-based interactive learning activities address lifestyle modification, pharmacotherapy, and bariatric surgery, and patient education resources are included to bolster physician recommendations and support patient success.
For additional information on this topic, clinicians can also download “Weight Can't Wait: A Guide for the Management of Obesity in the Primary Care Setting,” which was developed by The Stop Obesity Alliance and endorsed by 11 medical organizations, including ACP.
Nominations for awards, Masterships needed
ACP's Awards and Mastership Committees invite members' assistance in recognizing the accomplishments of distinguished individuals and organizations through the College's awards and Masterships program and is seeking nominations. The College offers 22 awards and a number of Masterships to recognize outstanding contributions in the practice of medicine, teaching, research, public service, leadership, and medical volunteerism. More information about the awards and Masterships process is online. The deadline for submission is July 1, 2021.
ICYMI: Highlights from ACP Internist Weekly
- ACC pathway supports neprilysin inhibitor, SGLT-2 inhibitors for heart failure with reduced ejection fraction. New therapies have emerged since a 2017 expert consensus decision pathway from the American College of Cardiology (ACC), and the updated pathway expands treatment options and provides practical tips, tables, and figures for treatment of heart failure with reduced ejection fraction. It was published Jan. 11 by the Journal of the American College of Cardiology and summarized in the Jan. 26 ACP Internist Weekly.
- Inappropriate medications prescribed in some Medicare patients with CKD. In an observational study of 3,624 patients enrolled in a Medicare Medication Therapy Management (MTM) plan in 2018, the odds of a potentially inappropriate medication were approximately seven to 14 times higher in those with stage 4 or 5 chronic kidney disease (CKD) versus those with stage 3. Potentially inappropriate medications were also associated with the number of years that a patient qualified for MTM, female sex, and increased polypharmacy. Results were published Jan. 27 by the Journal of General Internal Medicine and summarized in the Feb. 2 ACP Internist Weekly.